Charles Stacey

Charles Stacey

Dr. Stacey has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He is President and CEO of Cerecin, a biotechnology company focused on neurology drug development. Prior to Cerecin, Dr. Stacey worked in life science venture capital predominantly with Inventages, a global healthcare venture capital group with $1.5 billion AUM, where he focused on brain health. Before that, Dr. Stacey co-founded a medical device company to develop a product that he invented in his clinical practice. Earlier in his career, Dr. Stacey worked as an orthopaedics and trauma surgeon in London. Dr. Stacey is a member of Board of Governors for the Accreditation Council for Medical Affairs. He also acts as an investor and advisor to a number of life science companies. He received his medical degree from King's College London and completed an MBA at the London Business School and the Wharton School.

Speaker Articles

No items found.
Are you ready?

Get Early Access to
BioCon Asia-ACGT Conference!